| Dr Gregory Charles Wiggins, MD | |
|
601 John St, Suite M124, Kalamazoo, MI 49007-5341 | |
| (269) 341-7500 | |
| (269) 341-7540 |
| Full Name | Dr Gregory Charles Wiggins |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 29 Years |
| Location | 601 John St, Kalamazoo, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710961347 | NPI | - | NPPES |
| 0C97618 | Other | MI | BCBSM |
| 1710961347 | Medicaid | MI | |
| 00A816590 | Medicaid | CA | |
| 4843879 | Medicaid | MI |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bronson Methodist Hospital | Kalamazoo, MI | Hospital |
| Bronson Battle Creek Hospital | Battle creek, MI | Hospital |
| Three Rivers Health | Three rivers, MI | Hospital |
| Bronson South Haven Hospital | South haven, MI | Hospital |
| Bronson Lakeview Hospital | Paw paw, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bronson Methodist Hospital | 0244148633 | 598 |
News Archive
Patheon a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it has successfully released the first commercial shipments of SUMAVEL DosePro (sumatriptan injection) to Zogenix in anticipation of the planned U.S. commercial product launch scheduled in January 2010.
The CFO for Johnson & Johnson's said President Obama's deal with hospitals to cut Medicare costs will reduce the sales of medical devices, Bloomberg reports: "Hospitals buy medical devices, including J&J's artificial hips and stents to prop open clogged arteries, directly from the manufacturer, (Johnson and Johnson CFO Dominic) Caruso said today in an interview with Bloomberg News.
A research team at the Wyss Institute for Biologically Inspired Engineering at Harvard University leveraged its organ-on-a-chip technology to develop a model of the human small airway in which lung inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), the third leading cause of mortality worldwide, and asthma can be studied outside the human body.
Due to the increasing complexities of treating digestive diseases, allowing gastroenterological (GI) trainee physicians the opportunity to develop enhanced abilities and experiences in specific disease areas or procedures will be a great benefit to patients, according to a "Report of the Multisociety Task Force on GI Training."
Bacteria that cause tuberculosis, leprosy and other diseases, survive by switching between two different types of metabolism.
› Verified 5 days ago
| Entity Name | Bronson Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417961137 PECOS PAC ID: 0244148633 Enrollment ID: O20031208000832 |
News Archive
Patheon a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it has successfully released the first commercial shipments of SUMAVEL DosePro (sumatriptan injection) to Zogenix in anticipation of the planned U.S. commercial product launch scheduled in January 2010.
The CFO for Johnson & Johnson's said President Obama's deal with hospitals to cut Medicare costs will reduce the sales of medical devices, Bloomberg reports: "Hospitals buy medical devices, including J&J's artificial hips and stents to prop open clogged arteries, directly from the manufacturer, (Johnson and Johnson CFO Dominic) Caruso said today in an interview with Bloomberg News.
A research team at the Wyss Institute for Biologically Inspired Engineering at Harvard University leveraged its organ-on-a-chip technology to develop a model of the human small airway in which lung inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), the third leading cause of mortality worldwide, and asthma can be studied outside the human body.
Due to the increasing complexities of treating digestive diseases, allowing gastroenterological (GI) trainee physicians the opportunity to develop enhanced abilities and experiences in specific disease areas or procedures will be a great benefit to patients, according to a "Report of the Multisociety Task Force on GI Training."
Bacteria that cause tuberculosis, leprosy and other diseases, survive by switching between two different types of metabolism.
› Verified 5 days ago
| Entity Name | Bronson Battle Creek Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093119638 PECOS PAC ID: 0547173478 Enrollment ID: O20041103000774 |
News Archive
Patheon a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it has successfully released the first commercial shipments of SUMAVEL DosePro (sumatriptan injection) to Zogenix in anticipation of the planned U.S. commercial product launch scheduled in January 2010.
The CFO for Johnson & Johnson's said President Obama's deal with hospitals to cut Medicare costs will reduce the sales of medical devices, Bloomberg reports: "Hospitals buy medical devices, including J&J's artificial hips and stents to prop open clogged arteries, directly from the manufacturer, (Johnson and Johnson CFO Dominic) Caruso said today in an interview with Bloomberg News.
A research team at the Wyss Institute for Biologically Inspired Engineering at Harvard University leveraged its organ-on-a-chip technology to develop a model of the human small airway in which lung inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), the third leading cause of mortality worldwide, and asthma can be studied outside the human body.
Due to the increasing complexities of treating digestive diseases, allowing gastroenterological (GI) trainee physicians the opportunity to develop enhanced abilities and experiences in specific disease areas or procedures will be a great benefit to patients, according to a "Report of the Multisociety Task Force on GI Training."
Bacteria that cause tuberculosis, leprosy and other diseases, survive by switching between two different types of metabolism.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Charles Wiggins, MD 601 John St, Box 42, Kalamazoo, MI 49007-5341 Ph: (269) 341-7500 | Dr Gregory Charles Wiggins, MD 601 John St, Suite M124, Kalamazoo, MI 49007-5341 Ph: (269) 341-7500 |
News Archive
Patheon a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it has successfully released the first commercial shipments of SUMAVEL DosePro (sumatriptan injection) to Zogenix in anticipation of the planned U.S. commercial product launch scheduled in January 2010.
The CFO for Johnson & Johnson's said President Obama's deal with hospitals to cut Medicare costs will reduce the sales of medical devices, Bloomberg reports: "Hospitals buy medical devices, including J&J's artificial hips and stents to prop open clogged arteries, directly from the manufacturer, (Johnson and Johnson CFO Dominic) Caruso said today in an interview with Bloomberg News.
A research team at the Wyss Institute for Biologically Inspired Engineering at Harvard University leveraged its organ-on-a-chip technology to develop a model of the human small airway in which lung inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), the third leading cause of mortality worldwide, and asthma can be studied outside the human body.
Due to the increasing complexities of treating digestive diseases, allowing gastroenterological (GI) trainee physicians the opportunity to develop enhanced abilities and experiences in specific disease areas or procedures will be a great benefit to patients, according to a "Report of the Multisociety Task Force on GI Training."
Bacteria that cause tuberculosis, leprosy and other diseases, survive by switching between two different types of metabolism.
› Verified 5 days ago
Chris A Sloffer, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Suite M-124, Kalamazoo, MI 49007 Phone: 269-341-7500 Fax: 269-341-6894 | |
Dr. Eriks Antons Lusis, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1541 Gull Rd, Ste 200, Kalamazoo, MI 49048 Phone: 269-343-1264 | |
Mark E Meyer, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1541 Gull Rd, Suite 200, Kalamazoo, MI 49048 Phone: 269-343-1264 Fax: 269-343-9555 | |
Jonathan W. Hopkins, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1541 Gull Rd, Suite 200, Kalamazoo, MI 49048 Phone: 269-343-1264 Fax: 269-343-9555 | |
Richard A Dirrenberger, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1541 Gull Rd, Suite 200, Kalamazoo, MI 49048 Phone: 269-343-1264 Fax: 269-343-9555 | |
Mark J Krinock, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1541 Gull Rd, Suite 200, Kalamazoo, MI 49048 Phone: 269-343-1264 Fax: 269-343-9555 | |
Raghu Raj Singh, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 601 John St, Suite M124, Kalamazoo, MI 49007 Phone: 269-341-7500 Fax: 269-341-7540 |